Syk is low-expressed in non-small-cell lung cancer and inversely correlates with patient's survival

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 2, 2013, Pages 149-151

  Peng, Chuanliang ^a   Sun, Qifeng ^a   Hao, Yingtao ^a   Cong, Bo ^a   Zhao, Yunpeng ^a   Zhao, Xiaogang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CHINA; ENZYMOLOGY; FEMALE; HUMAN; INCIDENCE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK ASSESSMENT; STATISTICS; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; FEMALE; HUMANS; INCIDENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN-TYROSINE KINASES; RISK ASSESSMENT; STATISTICS AS TOPIC; SURVIVAL ANALYSIS; SURVIVAL RATE;

MLCS; MLOWN;

EID: 84880367574     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms102     Document Type: Article

References (13)

1. Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H and Zhang Z, et al. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 2003, 189: 97-102.
2. Zhang X, Shrikhande U, Alicie BM, Zhou Q and Geahlen RL. Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells. Mol Cancer Res 2009, 7: 634-644.
3. Nakashima H, Natsugoe S, Ishigami S, Okumura H, Matsumoto M, Hokita S and Aikou T. Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer. Cancer Lett 2006, 8: 89-94.
4. Layton T, Stalens C, Gunderson F, Goodison S and Silletti S. Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. Am J Pathol 2009, 175: 2625-2636.
5. Sung YM, Xu X, Sun J, Mueller D, Sentissi K, Johnson P and Urbach E, et al. Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. PloS One 2009, 4: e7445.
6. Coopman PJ and Mueller SC. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett 2006, 241: 159-173.
7. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO and Cui TG, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 2004, 64: 7822-7835.
8. Cross MJ, Dixelius J, Matsumoto T and Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 2003, 28: 488-494.
9. Lan F, Xiong S, Xiong W, Xu G and Li X. Expression of Syk in non-small cell lung cancer and its relationship with clinicopathological parameters. Front Med 2009, 3: 41-44.
10. Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E and Rashidi B, et al. Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 2004, 64: 7346-7354.
11. Ruschel A and Ullricb A. Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells. Cell Signal 2004, 16: 1249-1261.
12. Gatalica Z and Bing Z. Syk tyrosine kinase expression during multistep mammary carcinogenesis. Croat Med J 2005, 46: 372-376.
13. Chakraborty G, Rangaswami H, Jain S and Kundu GC. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. J Biol Chem 2006, 281: 11322-11331.